Stent Grafts
Lombard treats 1st U.S. patients with Aorfix flexible aortic stent graft
LeMaitre graft recall gets FDA’s highest warning
The FDA put its highest-risk Class I label on a recall issued by LeMaitre Vascular (NSDQ:LMAT) over leakage concerns for the Albograft vascular grafts.
U.S. Patent Office rules in favor of Bard in W.L. Gore infringement case
Lombard Medical lands Aorflex FDA approval, $32M
Fresh off of a $32 million funding round, Lombard Medical Technologies (LON:LMT) said it won pre-market approval from the FDA for the Aorflex delivery system used with its Aorfix stent graft for treating abdominal aortic aneurysms.
Medtronic’s Endurant II AUI stent graft wins FDA approval
Updated May 30, 2013, at 7:30 p.m. to correct that approval was granted for the Endurant II Aorto-Uni-Iliac stent graft system.
Medtronic (NYSE:MDT) said the FDA granted pre-market approval for its Endurant II Aorto-Uni-Iliac stent graft to treat abdominal aortic aneurysms and clearance for the Sentrant introducer sheath used with the AUI device.
Medtronic starts trial of Valiant Mona LSA aortic stent graft
California medtech start-up raises $6M of a $10M equity round
San Clemente, Calif.-based Altura Medical has raised $6 million of a hoped-for $10 million in equity funding, according to regulatory filings.
The privately held medical device startup didn’t disclose the names of the 4 investors currently subscribed to the financing round, but past investors include SV Life Sciences, New Leaf Venture Partners and Advanced Technology Ventures, according to a company statement.
C.R. Bard loses patent round, $25M hernia insurance decision
Kips Bay rises on FDA trial approval, despite losses in sales and revenue
Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full enrollment in the U.S. arm of a feasibility study.
FDA approves Lombard Med. Tech.’s Aorfix stent graft for treating highest neck angulation
British medical device maker Lombard Medical Technologies (LON:LMT) won premarket approval from the FDA to market its Aorfix flexible stent graft in the U.S.